This handsome book justly celebrates the achievements of Britain's most famous medical
journal, from its first issue in 1823 to 2005. The Lancet's present editor, Richard Horton …

My patients frequently ask,“Why does research take so long?”,“Why is progress so slow?”,
and “Why don't we have effective therapies for these devastating diseases?” At first thought …

This service will comprise reviews, editorials and original articles, and novel themes such as
'Ask the Experts','Journal Watch'and interviews. The journal intends to take full advantage of …

A multitude of diseases presenting a wide variety of phenotypic appearances are included in
neurodegenerative disorders. They are mainly characterized by the loss of specific …

Although substantial progress has been made in understanding the molecular and
pathological bases of neurodegeneration, there have been few successes in the clinic and a …

On 18 June 1993, I was sitting at my desk in the BMJ's editorial department on the second
floor of BMA House, a fine redbrick pile in Tavistock Square designed by Sir Edwin Lutyens …

In 1948, when the American Academy of Neurology (AAN) was founded, there were no
journals devoted exclusively to neurology. 1 To fill this void, and urged by Robert …

The knowledge in the pathophysiology of neurodegenerative disorders, and their
classification has been dramatically improved by the progresses in genetics and molecular …

Neurodegenerative diseases are a major global health burden in the Western world
particularly with our ageing population. The World Health Organization (WHO) predict that …

Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic
Advances Page 1 NEURODEGENERATIVE DISEASES Molecular and Cellular …